Table 1.
Antiviral nature of cyanobacteria
| S no. | Cyanobacterial potent for antiviral compound | Compound isolated | Natural product class | Target virus | Function | Reference |
|---|---|---|---|---|---|---|
| 1 | Nostoc ellipsosporum | Cyanovirin-N (CV-N) | Protein |
HIV HSV-6 MV SIV FIV HCV IV RVs SARS-CoV-2 EBOV HHV-6 |
Anti‐syncytia formation (inhibits the viral release) Inhibition of the viral entry by binding to the gp-120 |
Mazur-Marzec et al. (2021), Chatterjee et al. (2015), Barrientos et al. (2004), Li et al. (2022), Barrientos et al. (2003), Dey et al. (2000), O’Keefe et al. (2003), Singh et al. (2017), Smee et al. (2008, 2007) |
| 2 | Microcystis viridis | M. viridis lectin (MVL) | Protein |
HIV-1 HCV |
Reduction of initiation markers, such as CD69, CD25, and HLA-DR, by syncytium formation with healthy CD4 T cells | van Gremberghe et al. (2011) |
| 3 |
Microcystis aeruginosa |
Microvirin (MVN) |
Protein |
HIV-1 HCV |
Anti‐syncytia formation (Inhibit the viral release) | van Gremberghe et al. (2011) |
| 4 |
Scytonema varium |
Scytovirin (SVN) | Protein |
HIV HCV SARS-CoV-1 EBOV |
Binding to the viral coat proteins gp-120, gp160, and gp41 but not to cellular receptor CD4 or other tested proteins SVN inhibits the viral replication by binding to the mucin domain of the Ebola virus glycoprotein | Garrison et al. (2014) |
| 5 |
Oscillatoria agardhii |
Oscillatoria agardhii agglutinin (OAAH) |
Protein | HIV-1 and 2 | Inhibition of virus replication | Sato et al. (2007), Férir et al. (2014) |
| 6 | Aphanothece halophytica | Exopolysaccharide (EPS) | Exopolysaccharide | IAV | Inhibits very early step of viral replication, i.e., virus attachment and/or penetration to the host cells | Shalaby and Dubey (2018), Zheng et al. (2006) |
| 7 | Arthrospira platensis and Oscillatoria sp. | Methanol extract | NA | RV | Via binding to viral capsids preventing them from attaching to cell receptors | Deyab et al. (2020) |
| 8 |
Leptolyngbya boryana, Arthrospira platensis, Nostoc punctiforme, Oscillatoria sp., Leptolyngbya sp. |
Methanol extract | NA | CVB | Deyab et al. (2020) | |
| 9 | Microcystis, Nodularia, Oscillatoria, Scytonema, Lyngbya, and Calothrix | Aqueous and methanolic extract | NA | IAV | Inhibits virus replication via inhibition of specific protease enzymes | Zainuddin et al. (2002) |
| 10 | Microcystis ichthyoblabe | Ichthyopeptins A and B | Protein | IAV | Protease inhibition (inhibit virus) | Zainuddin et al. (2007) |
| 11 | Microcystis ichthyoblabe | Microginins | Peptides | SARS-CoV-2 | Inhibitory activity against angiotensin-converting enzyme (ACE) | Mazur-Marzec et al. (2021) |
| 12 | Scytonema sp. | Sulfoglycolipid (Sulfoquinovosyl diacylglycerol) | Lipid | HIV-1 | Inhibition of reverse transcriptase and DNA polymerases | Singh et al. (2011) |
| 13 | Spirulina platensis | Calcium spirulan (Ca-SP) | Sulfated polysaccharide |
MV, HSV-1, HCMV, IAV, MuV, HIV-1 |
Blockage of viral replication by inhibiting the penetration of the virus into the host cell | Hayashi et al. (1996) |
| 14 | Spirulina sp. | Pure Spirulina extract | NA | SARS-CoV-2 |
Via enhancement of T cell responses T helper cells targeting the spike protein of SARS-CoV-2. The strong T cell response will suppress SARS-CoV-2 infection further arresting its proliferation |
Peter (2020) |
| 15 | Nostoc flagelliforme | Nostoflan | Carbohydrates | HSV-1, HSV-2, CMV, and IAV | Inhibition of virus-cell interaction | Dembitsky and Řezanka (2005), Kanekiyo et al. (2005) |
| 16 |
Gloeocapsa turgidus, Synechococcus cedrorum |
Polysaccharides | Carbohydrates | RABV and HSV-1 | Anti-protease inhibition | Shalaby and Dubey (2018), Zheng et al. (2006) |
| 17 | Lyngbya confervoides | Lectin | Protein | HSV-1 | Inhibits plaque formation in the HSV-1 infected Vero cells | El-Fakharany et al. (2020) |
| 18 | Dichothrix baueriana |
Bauerines (A, B and C), b-carbolines polyhalogenated aromatic compound |
Indolo-quinazoline alkoloid | HSV-2 | Inhibit cytopathic effect (CPE) and reduce the number of plaques formed in infected mink lung cells | Larsen et al. (1994), Vasas et al. (2010) |
| 19 | Nostoc sphaericum |
Indolo [2,3-a]-3-methoxy-4- cyanocarbazole; N-methylindolo [2,3-a]-3-methoxy-4-cyanocarbazole |
Alkaloids | HSV-2 | Inhibits virus | Knübel et al. (1990) |
| 20 | Lyngbya lagerhimii, Phormidium tenue | Sulfolipids | Lipid | HIV | Inhibition of virus activity | Gustafson et al. (1989) |
| 21 | Trichodesmium erythraeum |
3-Methoxydebromoaply- siatoxin Anhydrodebromoaply-siatoxin Debromoaplysiatoxin |
NA | CHIKV | They target a step in the virus replication cycle that occurs after viral entry | Gupta et al. (2014) |
| 22 | Arthrospira platensis | Lipoprotein | Lipoprotein | IAV | Decreased histopathology | Pugh et al. (2015) |
| 23 | Arthrospira platensis | Lipoprotein | Lipoprotein | H1N1 | Upregulate IL‐1β, TNF‐α, (IL)–8, MCP‐1, MIP‐1, MIP‐1, IP‐10, COX‐2 | Pugh et al. (2015), Grzanna et al. (2006) |
| 24 | Arthrospira platensis | Arthrospira crude extract | NA | HSV-1 | Prevent virus adhesion to host cells | Shih et al. (2003) |
| 25 | Lyngbya majuscula | Dolastatin 3 | Peptides | HIV‐1 | Anti‐HIV‐1 integrase (inhibit the viral replication cycle) | Kanekiyo et al. (2007) |
| 26 | Spirulina platensis | Phycobili-protein | Protein | MS‐2 ΦX‐174 | Virucidal | Boyd et al. (1997) |
| 27 | Arthrospira platensis | Allophyco-cyanin | Protein | EV71 | Prevent virus adhesion to host cells | Lee et al. (2001) |
| 28 |
Nostoc, Phormidium, Oscillatoria, Chroococcus, Schizothrix, Aphanocapsa, Synechococcus, Aphanothece, Xenococcus |
Cyanobacterial extracts | NA | HIV‐1 | Anti‐RT (inhibit the viral replication cycle) | Buffa et al. (2009) |
HIV Human immunodeficiency virus, HSV-6 Human herpesvirus 6, MV Measles virus, SIV Simian immunodeficiency virus, FIV Feline immunodeficiency virus, HCV Hepatitis C virus, IAV Influenza A virus (IV), RVs Rhinoviruses, SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2, EBOV Ebolavirus, HHV-6 Human herpesvirus 6, RV Rotavirus, CVB Coxsackieviruses B, CMV Cytomegalovirus, MuV Mumps virus, RABV Rabies virus, HSV-2 Herpes simplex virus 2, CHIKV Chikungunya virus, H1N1 swine flu virus, EV71 Enterovirus‐71, NA not available